Showing results (321-330 of 338) with videos related to

Sort By:
Pageof 34
International Journal of Hematology|September 15, 2010
Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma studySung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
Elife|April 10, 2020
High-phytate/low-calcium diet is a risk factor for crystal nephropathies, renal phosphate wasting, and bone lossOk-Hee Kim, Carmen J Booth, Han Seok Choi, et al.
Nature Cancer|June 12, 2023
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancerChanghwan Sung, Jinhyeon An, Soohyeon Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 27, 2021
A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase InhibitorsByoung Chul Cho, Ji-Youn Han, Sang-We Kim, et al.
Diabetes & Metabolism Journal|November 29, 2024
Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes AssociationJaehyun Bae, Eugene Han, Hye Won Lee, et al.
Cancer Research and Treatment|November 7, 2023
Impact of Patient Sex on Adverse Events and Unscheduled Utilization of Medical Services in Cancer Patients Undergoing Adjuvant Chemotherapy: A Multicenter Retrospective Cohort StudySongji Choi, Seyoung Seo, Ju Hyun Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2024
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced MelanomaOmid Hamid, Karl D Lewis, Amy Weise, et al.
Cancer Medicine|December 10, 2021
The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter studyJwa Hoon Kim, Seyoung Seo, Jee Hyun Kim, et al.
Nature Genetics|July 4, 2012
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancerZhenfeng Zhang, Jae Cheol Lee, Luping Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2026
A first-in-human phase 1 clinical trial evaluating clinical activity and proof-of-mechanism of tobemstomig, a PD1-LAG3 bispecific antibody, in patients with CPI-experienced melanomaElena Garralda, Christoph Markert, Victor Moreno, et al.
Pageof 34